Just the berries: Restless legs syndrome

Canadian Family Physician

Volumn 46, Issue SEPT, 2000, Pages 1762-1763

  Hickey, J ^a  

^a St Martha's Regional Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; DEXTROPROPOXYPHENE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; IRON; LEVODOPA; OXYCODONE; PERGOLIDE;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; DRUG MONITORING; HUMAN; INSOMNIA; IRON DEFICIENCY; LEG MOVEMENT; NAUSEA; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; RESTLESS LEGS SYNDROME; RISK BENEFIT ANALYSIS; SLEEP DISORDER; VERTIGO; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; PARASOMNIA; REVIEW;

DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; LEVODOPA; NOCTURNAL MYOCLONUS SYNDROME; PERGOLIDE; PRACTICE GUIDELINES; RESTLESS LEGS SYNDROME;

EID: 0034269019     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review
2. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder
3. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria
4. Iron and the restless legs syndrome
5. Pergolide in the management of restless legs syndrome: An extended study
6. Treatment of restless leg syndrome with pergolide - An open clinical trial
7. Pergolide: Treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). Long-term follow up on pergolide. Short communication
8. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome
9. Treatment of restless legs syndrome with gabapentin